BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28646489)

  • 1. Functional analysis of p.Ala253_Leu254insAsn mutation in PLS3 responsible for X-linked osteoporosis.
    Wang L; Zhai Q; Zhao P; Xiang X; Zhang X; Tian W; Li T
    Clin Genet; 2018 Jan; 93(1):178-181. PubMed ID: 28646489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis.
    Laine CM; Wessman M; Toiviainen-Salo S; Kaunisto MA; Mäyränpää MK; Laine T; Pekkinen M; Kröger H; Välimäki VV; Välimäki MJ; Lehesjoki AE; Mäkitie O
    J Bone Miner Res; 2015 Mar; 30(3):510-8. PubMed ID: 25209159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLS3 mutations in X-linked osteoporosis with fractures.
    van Dijk FS; Zillikens MC; Micha D; Riessland M; Marcelis CL; de Die-Smulders CE; Milbradt J; Franken AA; Harsevoort AJ; Lichtenbelt KD; Pruijs HE; Rubio-Gozalbo ME; Zwertbroek R; Moutaouakil Y; Egthuijsen J; Hammerschmidt M; Bijman R; Semeins CM; Bakker AD; Everts V; Klein-Nulend J; Campos-Obando N; Hofman A; te Meerman GJ; Verkerk AJ; Uitterlinden AG; Maugeri A; Sistermans EA; Waisfisz Q; Meijers-Heijboer H; Wirth B; Simon ME; Pals G
    N Engl J Med; 2013 Oct; 369(16):1529-36. PubMed ID: 24088043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
    Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plastin 3 influences bone homeostasis through regulation of osteoclast activity.
    Neugebauer J; Heilig J; Hosseinibarkooie S; Ross BC; Mendoza-Ferreira N; Nolte F; Peters M; Hölker I; Hupperich K; Tschanz T; Grysko V; Zaucke F; Niehoff A; Wirth B
    Hum Mol Genet; 2018 Dec; 27(24):4249-4262. PubMed ID: 30204862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties.
    Balasubramanian M; Fratzl-Zelman N; O'Sullivan R; Bull M; Fa Peel N; Pollitt RC; Jones R; Milne E; Smith K; Roschger P; Klaushofer K; Bishop NJ
    Am J Med Genet A; 2018 Jul; 176(7):1578-1586. PubMed ID: 29736964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis.
    Wu Z; Feng Z; Zhu X; Dai Z; Min K; Qiu Y; Yi L; Xu L; Zhu Z
    Orphanet J Rare Dis; 2022 Jun; 17(1):247. PubMed ID: 35752817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.
    Kämpe AJ; Costantini A; Levy-Shraga Y; Zeitlin L; Roschger P; Taylan F; Lindstrand A; Paschalis EP; Gamsjaeger S; Raas-Rothschild A; Hövel M; Jiao H; Klaushofer K; Grasemann C; Mäkitie O
    J Bone Miner Res; 2017 Dec; 32(12):2394-2404. PubMed ID: 28777485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.
    Fahiminiya S; Majewski J; Al-Jallad H; Moffatt P; Mort J; Glorieux FH; Roschger P; Klaushofer K; Rauch F
    J Bone Miner Res; 2014 Aug; 29(8):1805-14. PubMed ID: 24616189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis.
    Mäkitie RE; Hackl M; Weigl M; Frischer A; Kämpe A; Costantini A; Grillari J; Mäkitie O
    J Bone Miner Res; 2020 Oct; 35(10):1962-1973. PubMed ID: 32453450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
    Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
    Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel frameshift deletion in PLS3 causing severe primary osteoporosis.
    Costantini A; Krallis PΝ; Kämpe A; Karavitakis EM; Taylan F; Mäkitie O; Doulgeraki A
    J Hum Genet; 2018 Aug; 63(8):923-926. PubMed ID: 29884797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plastin 1 promotes osteoblast differentiation by regulating intracellular Ca2.
    Wang L; Lan Y; Du Y; Xiang X; Tian W; Yang B; Li T; Zhai Q
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):563-569. PubMed ID: 32318696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
    Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mäkitie RE; Niinimäki T; Suo-Palosaari M; Kämpe A; Costantini A; Toiviainen-Salo S; Niinimäki J; Mäkitie O
    Front Endocrinol (Lausanne); 2020; 11():393. PubMed ID: 32655496
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plastin 3 in health and disease: a matter of balance.
    Wolff L; Strathmann EA; Müller I; Mählich D; Veltman C; Niehoff A; Wirth B
    Cell Mol Life Sci; 2021 Jul; 78(13):5275-5301. PubMed ID: 34023917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
    Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family.
    Wang L; Bian X; Cheng G; Zhao P; Xiang X; Tian W; Li T; Zhai Q
    Ann Hum Genet; 2020 Jan; 84(1):92-96. PubMed ID: 31347706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.